The protein P-S6S240 may serve as an indicator of poor prognosis for patients with a hard-to-treat type of uterine sarcoma called leiomyosarcoma, and preclinical data suggest that patients whose tumors have this protein may respond to PI3K/mTOR inhibitors.
from Top Health News – ScienceDaily http://ift.tt/2lOz9K5
from Tumblr http://ift.tt/2luIUwl
No comments:
Post a Comment